|
Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures Clinical research trials and Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures. Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures clinical trial. Human subjects often get the best healthcare possible for their Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures
Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures
For Condition: Rest Leg Pain,Peripheral Vascular Disease,Critical Limb Ischemia,Foot Ulcers
Status: Recruiting
Sponsor(s): United Therapeutics ,
Synopsis: The purpose of this study is to assess and compare the safety of continuous and daily subcutaneous Remodulin therapy in patients with critical limb ischemia (CLI) with no planned vascular interventional procedures; and to determine the effect of Remodulin on wound healing and treadmill walk distance.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/85 Years
Genders: Both
Protocol Entry Criteria: Patients with Stage III or IV critical limb ischemia due to documented peripheral arterial disease with no planned interventional vascular procedures
Total Enrollment: 30
Location and Contact Information:
Overall Study Official:
MichaelWade, Study Director, United Therapeutics
University of South Florida College of Medicine *Recruiting*
Tampa, Florida, 33606
United States
Recruiting Jamie Parker 813-259-0683
South Carolina Heart Center *Recruiting*
Columbia, South Carolina, 29204
United States
Recruiting Kelly Crump 800-714-3278
University of Massachusetts Memorial Health *Recruiting*
Worcester, Massachusetts, 01655
United States
Recruiting Mary Martella 508-856-6834
The Methodist Hospital *Recruiting*
Houston, Texas, 77030
United States
Recruiting Kelly Maresch 713-790-4410
Oregon Health Sciences University *Recruiting*
Portland, Oregon, 97239
United States
Recruiting Rakhee Urankar 503-494-4334
Minneapolis Heart Institute *Recruiting*
Minneapolis, Minnesota, 55407-1139
United States
Recruiting JoAnne Goldman 612-863-3793
Presbyterian Medical Center, Philadelphia Heart Institute *Recruiting*
Philadelphia, Pennsylvania, 19104
United States
Recruiting Elizabeth Medenila 215-662-9740
Additional Information:
Study ID Numbers: REM 03:202;
Study Start Date: February 2003
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00060996
Other Foot Ulcers Studies:
1. Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures
Related Studies:
Other Foot Ulcers Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures
|
|
|
|
|
|
|
|